Biotech Values

[DewDiligence]

MNTA – From the 2Q08 CC transcript (#msg-31026200):

>>
Earlier in July, Teva and Amphastar were granted an extension until August 21st to file a response to the Sanofi-Aventis petition for rehearing. Furthermore, several parties, including Pharma and Bio, have filed amicus briefs in support of the petition for a rehearing. All of these actions are extending the period of time it will take for the court of appeals to consider the petition. Historic data suggests courts typically rule on a rehearing request within one to two months after the briefs are submitted. But there is no required timeline on the court.
<<